CRNX

Crinetics Pharmaceuticals Inc Q3 Loss Increases, Misses Estimates

(RTTNews) - Crinetics Pharmaceuticals Inc (CRNX) reported Loss for its third quarter that increased from the same period last year and missed the Street estimates.

The company's earnings came in at -$130.09 million, or -$1.38 per share. This compares with -$76.83 million, or -$0.96 per share, last year.

Analysts on average had expected the company to earn -$1.25 per share. Analysts' estimates typically exclude special items.

Crinetics Pharmaceuticals Inc earnings at a glance (GAAP) :

-Earnings: -$130.09 Mln. vs. -$76.83 Mln. last year. -EPS: -$1.38 vs. -$0.96 last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.